CART CD1a/OC-1.2 Immunotherapy

N/A

Report date: 2023/09/08 17:40:32

Base Information

Drug NameCART CD1a/OC-1.2 Immunotherapy

Drug Alias NameOC-1d

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy

Mechanisms of ActionAnti-T-cell surface glycoprotein CD1a

TargetsT-cell surface glycoprotein CD1a

Therapy Area/IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOnechain Immunotherapeutics SL

China Registration ClassN/A

Develop Information

Active CompaniesOnechain Immunotherapeutics SL

Inactive CompaniesN/A

Active IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A